Ri
Ring Ther
Cambridge MAFounded 201780 employees
Private CapbiotechPrivateGenetic Medicine
Platform: Anellovirus
Market Cap
N/A
All Drugs
4
Clinical Trials
10
Failed / Terminated
2
FDA Approved
1
Drug Pipeline (4 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| RIN-7561 | RIN-7561 | Approved | 1 | CDK4/6 | DMD | ||
| RIN-657 | RIN-657 | Phase 1 | 1 | CDK2 | CML | ||
| RIN-582 | RIN-582 | Phase 3 | 4 | SMN2 | IgAN | ||
| Nirainavolisib | RIN-4595 | Phase 3 | 4 | IL-13 | FTDOCD |
Financial Documents
This is a private company — SEC filings are not available.
Catalyst Events (7)